Abbott Set To Launch Xience Prime Stents In India; Says Solvay's Products Will Broaden Focus

MUMBAI - As part of its strategy to focus sharply on India, illustrated by two acquisitions that expand its therapeutic presence significantly, Abbott is set to bring to India its next-generation drug-eluting stent Xience Prime by the fourth quarter of 2009